| Browse All

Septerna, Inc. (SEPN)

Healthcare | Biotechnology | South San Francisco, United States | NasdaqGM
26.13 USD +1.14 (4.562%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 26.23 +0.10 (0.387%) ⇧ (April 17, 2026, 5:48 p.m. EDT)

Short-term: ★★☆☆☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 11, 2026, 4:17 p.m. EDT

SEPN is a high-risk, high-reward stock with a strong potential for growth due to recent positive news and analyst recommendations. However, the company is currently unprofitable and has a high overall risk score. The recent price action shows some volatility, with a dip on April 10, which could present a buying opportunity for short-term traders. Long-term investors should consider the company's fundamentals and the potential for growth, especially with the upcoming Phase 1 results. Dividend investors should avoid this stock as it has no dividend history.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.063753
AutoARIMA0.064249
AutoETS0.064250
AutoTheta0.073248

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 80%
H-stat 0.36
Ljung-Box p 0.000
Jarque-Bera p 0.117
Excess Kurtosis -0.55
Attribute Value
Sector Healthcare
Debt to Equity Ratio 6.186
Revenue per Share 1.038
Market Cap 1,173,403,520
Forward P/E -13.43
Profit Margins -106.37%
Website https://septerna.com

As of April 11, 2026, 4:17 p.m. EDT: Options speculators are showing mixed signals. For the near-term, there's a concentration of open interest and volume in calls around the $24 strike, indicating potential bullish sentiment. However, the high IV for out-of-the-money strikes suggests uncertainty or speculation about a potential move. Puts show some activity, particularly around the $25 strike, which might indicate caution. The overall options data suggests a potential for volatility with a slight bias towards bullish sentiment, but the market is still uncertain.


Info Dump

Attribute Value
52 Week Change 3.2572403
Address1 250 East Grand Avenue
All Time High 32.63
All Time Low 4.17
Ask 26.33
Ask Size 1
Audit Risk 6
Average Analyst Rating 1.1 - Strong Buy
Average Daily Volume10 Day 323,020
Average Daily Volume3 Month 298,655
Average Volume 298,655
Average Volume10Days 323,020
Bid 25.89
Bid Size 1
Board Risk 10
Book Value 8.524
City South San Francisco
Compensation As Of Epoch Date 1,735,603,200
Compensation Risk 9
Country United States
Crypto Tradeable 0
Currency USD
Current Price 26.13
Current Ratio 4.727
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 26.57
Day Low 24.84
Debt To Equity 6.186
Display Name Septerna
Earnings Timestamp 1,773,086,400
Earnings Timestamp End 1,778,184,000
Earnings Timestamp Start 1,778,184,000
Ebitda -79,193,000
Ebitda Margins -1.7234199
Enterprise To Ebitda -10.177
Enterprise To Revenue 17.539
Enterprise Value 805,939,584
Eps Current Year -1.19309
Eps Forward -1.94518
Eps Trailing Twelve Months -1.1
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 26.1164
Fifty Day Average Change 0.013599396
Fifty Day Average Change Percent 0.0005207225
Fifty Two Week Change Percent 325.72403
Fifty Two Week High 32.63
Fifty Two Week High Change -6.500002
Fifty Two Week High Change Percent -0.19920324
Fifty Two Week Low 5.73
Fifty Two Week Low Change 20.4
Fifty Two Week Low Change Percent 3.5602093
Fifty Two Week Range 5.73 - 32.63
Financial Currency USD
First Trade Date Milliseconds 1,729,863,000,000
Float Shares 22,896,413
Forward Eps -1.94518
Forward P E -13.433204
Free Cashflow 18,810,876
Full Exchange Name NasdaqGM
Full Time Employees 130
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 1.0
Gross Profits 45,951,000
Has Pre Post Market Data 1
Held Percent Insiders 0.03139
Held Percent Institutions 1.02975
Implied Shares Outstanding 44,906,374
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,024-10-25
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Long Name Septerna, Inc.
Market us_market
Market Cap 1,173,403,520
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_1765584396
Most Recent Quarter 1,767,139,200
Net Income To Common -48,879,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 1,122,210,286
Number Of Analyst Opinions 7
Open 25.5
Operating Cashflow 110,189,000
Operating Margins -0.66436
Overall Risk 9
Payout Ratio 0.0
Phone 650 338 3533
Post Market Change 0.101200104
Post Market Change Percent 0.3872947
Post Market Price 26.2312
Post Market Time 1,776,462,488
Previous Close 24.99
Price Eps Current Year -21.901114
Price Hint 2
Price To Book 3.065462
Price To Sales Trailing12 Months 25.535973
Profit Margins -1.06372
Quick Ratio 4.657
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.125
Region US
Regular Market Change 1.14
Regular Market Change Percent 4.56182
Regular Market Day High 26.57
Regular Market Day Low 24.84
Regular Market Day Range 24.84 - 26.57
Regular Market Open 25.5
Regular Market Previous Close 24.99
Regular Market Price 26.13
Regular Market Time 1,776,456,000
Regular Market Volume 379,455
Return On Assets -0.09594
Return On Equity -0.12189999
Revenue Growth 112.764
Revenue Per Share 1.038
Sand P52 Week Change 0.36506534
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 44,906,374
Shares Percent Shares Out 0.048499998
Shares Short 2,176,719
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 1,848,804
Short Name Septerna, Inc.
Short Percent Of Float 0.0833
Short Ratio 7.48
Source Interval 15
State CA
Symbol SEPN
Target High Price 60.0
Target Low Price 35.0
Target Mean Price 44.42857
Target Median Price 43.0
Total Cash 391,088,992
Total Cash Per Share 8.709
Total Debt 23,625,000
Total Revenue 45,951,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.1
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 21.21005
Two Hundred Day Average Change 4.9199486
Two Hundred Day Average Change Percent 0.23196308
Type Disp Equity
Volume 379,455
Website https://septerna.com
Zip 94,080